Company

Chiara Biosciences

Biotechnology Research Denver, Colorado, United States 7 employees

Employees: 7
Contacts: 4
Emails: 4
Phones: 3

www.chiarabio.com LinkedIn

Chiara Biosciences Overview

Headquarters: Denver, Colorado, United States
Website: www.chiarabio.com
Industry: Biotechnology Research
Employees: 7
Founded: 2024
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Asha Therapeutics

About Chiara Biosciences

Chiara Biosciences is revolutionizing Targeted Protein Degradation (TPD) with its proprietary CURE-PRO (Combinatorial Ubiquitination REal-time PROteolysis) platform. CURE-PROs are small-molecule degraders that self-assemble inside cells using novel linker chemistry—one molecule engages an E3 ligase and another engages the target protein. This approach enables oral administration, enhanced cell/tissue penetration, and central nervous system accessibility. Chiara’s unique combinatorial strategy supports a high-throughput, reusable platform for developing both an internal pipeline and collaborative solutions for strategic CURE-PRO development. See www.chiarabio.com to learn more.

Chiara Biosciences Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 3; 75.0% coverage

Chiara Biosciences Org Chart

Sample employees and titles

Name	Title	Location	Contact
Rich Woessner	Oncology Drug Discovery and Preclinical Pharmacology Consultant	Boulder, Colorado, United States	Email Phone
Kirsten Flowers	Chief Executive Officer - Board Member	Denver Metropolitan Area, United States	Email Phone
Francis Barany	Professor at Weill Cornell Medical College	New York City Metropolitan Area, United States	Email Phone
James Winkler	Drug Discovery and Development Consultant	Boulder, Colorado, United States	Email